Educational Risk Minimisation Materials to help reduce the risk associated with using vedolizumab (Entyvio) in the treatment of ulcerative colitis and Crohn’s disease

An educational brochure for healthcare professionals discusses the risk of progressive multifocal leukoencephalopathy, including considerations prior to treatment, monitoring recommendations, and discussing risks with patients. A patient alert card is also available.

Takeda